Brief: Daxor - Announces Data On Bva-100 Blood Test In Heart Failure (Hf) Patients Published In Journal Of Cardiac Failure
17/02/2022 13:21
Feb 17 (Reuters) - Daxor Corp DXR.O :
* DAXOR - ANNOUNCES DATA DEMONSTRATING IMPORTANCE & CLINICAL
UTILITY OF DAXOR'S BVA-100 BLOOD TEST IN HEART FAILURE (HF)
PATIENTS PUBLISHED IN JOURNAL OF CARDIAC FAILURE
Source text for Eikon: ID:nGNXb8gqZh
Further company coverage: DXR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Daxor
See all newsNASDAQ RESUMED AT 02:03 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:58 PM
Brief: Daxor Corp Reaffirms Focus On Blood Volume Analysis Technology
Brief: Daxor Corporation Submits 510(K) To FDA For Next-Generation Blood Volume Analyzer
Brief: Daxor Corporation Streamlines Regulatory Strategy For Groundbreaking Diagnostic Device